Patents by Inventor Andy Futreal

Andy Futreal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for detection of the oncogenic T1796A B-Raf mutation
    Patent number: 8580497
    Abstract: The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumors of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: November 12, 2013
    Assignee: The Wellcome Trust
    Inventors: Mike Stratton, Andy Futreal, Richard Wooster, Richard Malcolm Marais, Chris Marshall
  • GENES
    Publication number: 20110189688
    Abstract: The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
    Type: Application
    Filed: December 2, 2010
    Publication date: August 4, 2011
    Inventors: Mike Stratton, Andy Futreal, Richard Wooster, Richard Malcolm Marais, Chris Marshall
  • B-raf polynucleotides
    Patent number: 7947819
    Abstract: The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumors of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: May 24, 2011
    Assignee: The Wellcome Trust
    Inventors: Mike Stratton, Andy Futreal, Richard Wooster, Richard Malcolm Marais, Chris Marshall
  • Genes
    Publication number: 20050186584
    Abstract: The invention relates to mutations in B-Raf gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, and the development of anti-cancer therapeutics.
    Type: Application
    Filed: June 21, 2004
    Publication date: August 25, 2005
    Inventors: Mike Stratton, Andy Futreal, Richard Wooster, Richard Marais, Chris Marshall